Curis Lifesciences Complete Financial Statements

CURIS • Review detailed financials to uncover trends, confirm thesis & journal trades
4 Years of Data
2025 - 2022

Complete Financial Data Export

Export complete financial statements for Curis Lifesciences (CURIS). Downloads include all available records across all periods. For market performance, see the CURIS stock price today .

Profitability Ratios

Net Profit Margin 11.11% 2024 data
EBITDA Margin 33.33% 2024 data
Operating Margin 30.00% 2024 data
Return on Assets 2.33% 2024 data
Return on Equity 6.25% 2024 data

Balance Sheet Ratios

Current Ratio 3.44 2024 data
Debt to Equity 2.69 2024 data
Equity Ratio 37.21% 2024 data
Asset Turnover 0.21 2024 data

Year-over-Year Growth Analysis

Assets Growth
+26.5%
Year-over-Year
Equity Growth
+166.7%
Year-over-Year
Liabilities Growth
+26.5%
Year-over-Year

Income Statement

Periods ₹ Crores
Particulars Jun 2024
Revenue 9
Expenses 6
EBITDA 3
Operating Profit Margin % 30.00%
Depreciation 0
Interest 0
Profit Before Tax 2
Tax 1
Net Profit 1
Earnings Per Share (₹) 24.00

Balance Sheet

Years Annual Data ₹ Crores
Particulars 2025 2024 2023 2022
ASSETS
Total Assets 43 34 30 27
Current Assets 31 22 17 15
Fixed Assets 11 12 12 12
Capital Work in Progress 0 0 0 0
Investments 0 0 0 0
Other Assets 32 22 18 15
LIABILITIES
Total Liabilities 43 34 30 27
Current Liabilities 9 10 10 13
Non-Current Liabilities
SHAREHOLDERS' EQUITY
Total Equity 16 6 0 -1
Share Capital 6 1 1 1
Reserves & Surplus 10 5 0 -1

Cash Flow Statement

Periods ₹ Crores
Particulars March 2025 March 2024 March 2023 March 2022
Operating Activities -2 0 3 5
Investing Activities 0 0 -1 0
Financing Activities 2 0 -3 -5
Net Cash Flow 0 0 0 0